Ardent Health (NYSE:ARDT) Given New $12.00 Price Target at Mizuho

Ardent Health (NYSE:ARDT) had its price objective lowered by Mizuho from $20.00 to $12.00 in a report published on Thursday, MarketBeat reports. The firm currently has an outperform rating on the stock.

ARDT has been the subject of several other research reports. The Goldman Sachs Group assumed coverage on shares of Ardent Health in a report on Tuesday, October 14th. They issued a “neutral” rating and a $19.00 price target for the company. Leerink Partners set a $16.00 price target on Ardent Health in a research note on Friday, November 14th. Truist Financial dropped their price objective on Ardent Health from $21.00 to $13.00 and set a “buy” rating on the stock in a research note on Friday, November 14th. Stephens decreased their price target on shares of Ardent Health from $21.00 to $17.00 and set an “overweight” rating on the stock in a research note on Friday, November 14th. Finally, Royal Bank Of Canada decreased their price target on shares of Ardent Health from $21.00 to $16.00 and set an “outperform” rating on the stock in a research note on Friday, November 14th. Six analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $14.67.

Ardent Health Stock Performance

ARDT stock opened at $8.94 on Thursday. The company has a 50 day moving average price of $11.59 and a 200 day moving average price of $12.42. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.08 and a quick ratio of 1.95. The stock has a market capitalization of $1.28 billion, a PE ratio of 6.16, a price-to-earnings-growth ratio of 7.36 and a beta of 0.77. Ardent Health has a fifty-two week low of $8.28 and a fifty-two week high of $17.34.

Ardent Health (NYSE:ARDT) last released its earnings results on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.10. Ardent Health had a net margin of 3.24% and a return on equity of 19.02%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.55 billion. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. Analysts forecast that Ardent Health will post 1.23 EPS for the current year.

Hedge Funds Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Ameriprise Financial Inc. raised its position in Ardent Health by 8.2% in the third quarter. Ameriprise Financial Inc. now owns 1,769,335 shares of the company’s stock valued at $23,444,000 after purchasing an additional 134,513 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Ardent Health by 44.5% in the third quarter. Vanguard Group Inc. now owns 1,352,676 shares of the company’s stock valued at $17,923,000 after buying an additional 416,348 shares during the period. Millennium Management LLC increased its stake in shares of Ardent Health by 6.6% in the third quarter. Millennium Management LLC now owns 1,269,605 shares of the company’s stock valued at $16,822,000 after buying an additional 78,861 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Ardent Health by 1.4% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 828,611 shares of the company’s stock valued at $11,377,000 after buying an additional 11,429 shares during the last quarter. Finally, SageView Advisory Group LLC boosted its position in Ardent Health by 367.2% during the 2nd quarter. SageView Advisory Group LLC now owns 790,663 shares of the company’s stock worth $10,800,000 after buying an additional 621,430 shares during the period.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.